1. Home
  2. Share Market
  3. Stocks
  4. Torrent Pharmaceuticals
  5. Financial Statements
  6. Annually Results

TORNTPHARM Financial Statements

TORNTPHARM Annual Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 0.83 32.30 2.48 (12)
Op profit growth 14.50 60.90 (2) (50)
EBIT growth 15.10 32.10 (4.20) (52)
Net profit growth 22.20 51.10 (27) (46)
Profitability ratios (%)        
OPM 31.10 27.30 22.50 23.50
EBIT margin 23.50 20.60 20.70 22.10
Net profit margin 15.60 12.90 11.30 15.90
RoCE 16.30 14.50 13.70 19.60
RoNW 5.87 5.42 3.78 5.95
RoA 2.71 2.27 1.88 3.53
Per share ratios ()        
EPS 74 60.60 40.10 55.20
Dividend per share 35 32 14 14
Cash EPS 35.10 21.90 15.90 37
Book value per share 345 285 273 257
Valuation ratios        
P/E 34.40 32.60 31.10 28.10
P/CEPS 72.40 90.10 78.40 41.80
P/B 7.37 6.92 4.57 6.03
EV/EBIDTA 18.60 16.80 16.20 17.40
Payout (%)        
Dividend payout -- -- 35 25.40
Tax payout (18) (14) (27) (14)
Liquidity ratios        
Debtor days 72.30 66.70 67 74.70
Inventory days 110 94.60 107 90.90
Creditor days (137) (131) (154) (170)
Leverage ratios        
Interest coverage (5.30) (3.60) (4) (6.30)
Net debt / equity 0.72 1.06 1.21 0.37
Net debt / op. profit 1.70 2.36 4.15 1.17
Cost breakup ()        
Material costs (27) (27) (28) (31)
Employee costs (18) (18) (19) (17)
Other costs (24) (27) (31) (29)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 8,005 7,939 6,002 5,857
yoy growth (%) 0.83 32.30 2.48 (12)
Raw materials (2,146) (2,167) (1,673) (1,792)
As % of sales 26.80 27.30 27.90 30.60
Employee costs (1,440) (1,429) (1,135) (993)
As % of sales 18 18 18.90 17
Other costs (1,933) (2,173) (1,844) (1,695)
As % of sales 24.10 27.40 30.70 28.90
Operating profit 2,486 2,170 1,349 1,377
OPM 31.10 27.30 22.50 23.50
Depreciation (658) (654) (409) (307)
Interest expense (358) (451) (308) (206)
Other income 56.70 121 299 223
Profit before tax 1,526 1,187 931 1,088
Taxes (274) (162) (253) (155)
Tax rate (18) (14) (27) (14)
Minorities and other -- -- -- --
Adj. profit 1,252 1,025 678 934
Exceptional items -- -- -- --
Net profit 1,252 1,025 678 934
yoy growth (%) 22.20 51.10 (27) (46)
NPM 15.60 12.90 11.30 15.90
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 1,526 1,187 931 1,088
Depreciation (658) (654) (409) (307)
Tax paid (274) (162) (253) (155)
Working capital 1,742 1,240 891 175
Other operating items -- -- -- --
Operating cashflow 2,336 1,610 1,160 802
Capital expenditure 9,547 9,134 8,171 3,490
Free cash flow 11,883 10,744 9,331 4,292
Equity raised 5,523 4,908 5,518 5,387
Investments 35.20 (122) 432 618
Debt financing/disposal 4,541 5,617 6,067 1,871
Dividends paid -- -- 237 237
Other items -- -- -- --
Net in cash 21,982 21,148 21,585 12,405
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 84.60 84.60 84.60 84.60
Preference capital -- -- -- --
Reserves 5,753 4,739 4,640 4,538
Net worth 5,837 4,823 4,724 4,622
Minority interest
Debt 4,825 5,784 6,038 6,462
Deferred tax liabilities (net) 964 862 827 0.04
Total liabilities 11,626 11,469 11,590 11,085
Fixed assets 7,954 8,245 8,365 8,502
Intangible assets
Investments 181 2.11 353 492
Deferred tax asset (net) 1,386 1,295 1,190 276
Net working capital 1,502 1,261 866 948
Inventories 2,681 2,148 1,935 1,966
Inventory Days 122 98.80 -- 120
Sundry debtors 1,523 1,649 1,436 1,253
Debtor days 69.50 75.80 -- 76.20
Other current assets 710 865 846 886
Sundry creditors (2,089) (2,063) (2,135) (2,090)
Creditor days 95.30 94.80 -- 127
Other current liabilities (1,323) (1,339) (1,216) (1,069)
Cash 604 667 816 867
Total assets 11,626 11,469 11,590 11,085
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Mar-2021 Mar-2020 Mar-2019 Mar-2018
Gross Sales 8,419 7,886 7,780 7,462 5,825
Excise Duty -- -- -- -- --
Net Sales 8,419 7,886 7,780 7,462 5,825
Other Operating Income 89 119 159 211 125
Other Income 197 57 122 57 299
Total Income 8,705 8,062 8,061 7,730 6,249
Total Expenditure ** 6,562 5,520 5,769 6,046 4,601
PBIDT 2,143 2,542 2,292 1,684 1,648
Interest 255 358 451 504 308
PBDT 1,888 2,184 1,841 1,180 1,340
Depreciation 662 658 654 618 409
Minority Interest Before NP -- -- -- -- --
Tax 342 327 274 281 261
Deferred Tax 107 (53) (112) (155) (8)
Reported Profit After Tax 777 1,252 1,025 436 678
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 777 1,252 1,025 436 678
Extra-ordinary Items (307) -- -- (179) --
Adjusted Profit After Extra-ordinary item 1,084 1,252 1,025 615 678
EPS (Unit Curr.) 45.90 74 60.60 25.80 40.10
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) 960 700 640 340 280
Equity 84.60 84.60 84.60 84.60 84.60
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 25.50 32.20 29.50 22.60 28.30
PBDTM(%) 22.40 27.70 23.70 15.80 23
PATM(%) 9.23 15.90 13.20 5.84 11.60

QuickLinks for Torrent Pharmaceuticals Ltd.

TORNTPHARM News

TORNTPHARM Information

TORNTPHARM Financials

TORNTPHARM Documents

Open ZERO Brokerage Demat Account
Open Demat Account

  • ₹0

    Per Order for ETF & Mutual Funds Brokerage

  • ₹20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity